United States: Attorney Says PCCPs With Change In Indication For Use Not Completely Impracticable - Morrison & Foerster LLP
Friday, 1 September 2023
Brigid Bondoc spoke to BioWorld about the U.S. Food and Drug Administration's draft guidance for predetermined change control protocols (PCCPs).
|
||||
You Might Like |
||||
